Ex-BMS execs strike deals on US securities fraud case
This article was originally published in Scrip
Executive Summary
Former Bristol-Myers Squibb finance chief Frederick Schiff and former executive vice-president of BMS worldwide medicines Richard Lane have reached deals with US prosecutors under which all criminal charges in the five-year-old case will be dismissed if they stay out of trouble for 12 months. It was alleged that the two provided misleading information to investors as part of a "channel stuffing" scheme to artificially inflate company profits.